glp-1 antidepressant Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence How GLP-1 medications are transforming

Hu QP, Mao DA

In the official clinical guidelines of the American Thoracic Society for the role of weight management in the treatment of adults with OSA it was stated that individuals with BMI 27 kg/m 2 (in whom body weight has not been improved despite lifestyle modifications) can be evaluated for anti-obesity pharmacotherapy, although currently there is insufficient evidence to recommend any pharmacotherapy [31, 32]

Assembly of Kafirin/Carboxymethyl Chitosan Nanoparticles to Enhance the Cellular Uptake of Curcumin

superoxide dismutases (SODs), CAT and glutathione peroxidases (GPXs))

A sedentary lifestyle with lowered expression of PGC-1alpha is associated with weight gain, inflammation, and decreased insulin secretion, pathological changes that eventually culminate in T2DM and obesity (191) (Table 3)